Guilingan, Aicel .

HRN: 27-98-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2025
CEFUROXIME 1.5GM (VIAL)
10/22/2025
10/22/2025
IV
1.5gm
PTOR
Pre Op Prophylaxis
Waiting Final Action 
10/23/2025
CEFUROXIME 500MG (TAB)
10/23/2025
10/29/2025
PO
500mg Tab
1 Tab BID X 7 Days
S/p Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: